Pharmaceutical Regulation Tightening Expands Lidding Film Specification
Pharmaceutical contract packagers are increasingly specifying peelable lidding film with validated seal strength consistency for child-resistant and tamper-evident blister formats, since regulatory compliance documentation now shapes film procurement decisions as directly as cost once did on its own. Roughly 20 percent of new pharmaceutical blister specifications since 2023 call for certified peel force consistency documentation, reflecting growing brand recognition that validated seal performance increasingly determines which converters win long-term contract packaging agreements. Regulatory tightening across North American and European child-resistant packaging standards is compounding this specification shift faster than qualification capacity plans anticipated two years ago. A closely related view comes from the peelable lid stock market, which MMA projects to grow at a 6.3% CAGR to USD 1.67 billion by 2036.
Market Impact: Packaging volume grew 4% in 2024








